BioCentury
ARTICLE | Clinical News

Lonafarnib regulatory update

May 4, 2015 7:00 AM UTC

FDA granted Fast Track designation to lonafarnib from Eiger to treat HDV infection in combination with ritonavir. The farnesyl transferase inhibitor is in Phase II testing for the indication, for whi...